<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="39861">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02587481</url>
  </required_header>
  <id_info>
    <org_study_id>15-057</org_study_id>
    <nct_id>NCT02587481</nct_id>
  </id_info>
  <brief_title>Pneumological Acute Coronary Syndrom (ACS) Phenotyping Aachen</brief_title>
  <acronym>PAPA</acronym>
  <official_title>Pneumological Phenotyping of Acute Coronary Syndrom (ACS) Patients Concerning Concomitant Chronic Obstructive Pulmonary Disease (COPD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this open, monocentric, observational study acute coronary syndrom (ACS) patients will be
      characterized by pneumological examination concerning a concomitant chronic obstructive
      pulmonary disease (COPD). Often COPD coexists with ACS; therefore ACS patients benefit
      either from prevention or potential therapy of chronic hypoxia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study patients with either non ST-segment-elevation myocardial infarction (NSTEMI)
      or ST-segment-elevation myocardial infarction (STEMI) will be included. After amnesis
      patients will undergo blood withdrawal, blood-gas analysis and examinations concerning
      pulmonary function (Bodyplethysmography). In addition to routine blood withdrawal for
      differential blood count, 9 ml blood sample is takenfor molecular analysis of relevant
      prognostic chronic obstructive pulmonary disease (COPD)-blood based biomarkers, an for
      establishing a library of biomaterial in form of a biobank.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with Acute Coronary Syndrom (ACS) and concomitant Chronic Obstructive Pulmonary Disease (COPD)</measure>
    <time_frame>During 1-2 hours (at time of examination)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Molecular analysis of relevant blood based chronic obstructive pulmonary disease (COPD) biomarkers</measure>
    <time_frame>An average of 1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Acute Coronary Syndrom</condition>
  <condition>Chronic Obstructive Pulmonary Syndrom</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, Blood plasm
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with either non ST-segment-elevation myocardial infarction (NSTEMI) or
        ST-segment-elevation myocardial infarction (STEMI)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written declaration of consent

          -  Patients with acute myocardial infarct which can be either non ST-segment-elevation
             myocardial infarct (NSTEMI) or ST-segment-elevation myocardial infarct (STEMI), in
             both cases exaggeration of cardiac ischaemic markers

        Exclusion Criteria:

          -  Patients not fulfilling the incluson criterias or:

          -  Pregnant or breastfeeding women

          -  Participation in other studies

          -  Persons in depency from the sponsor or working with the sponsor

          -  Persons without mental ability or capacity to understand and follow the instructions
             of the investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Dreher, Univ.-Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Hospital MK1</affiliation>
  </overall_official>
  <overall_official>
    <last_name>VIncent Brandenburg, apl. Prof. Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Hospital MK1</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Cornelissen, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Hospital MK1</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amrei Pelzer</last_name>
    <phone>00492418035768</phone>
    <email>apelzer@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Verena Deserno</last_name>
    <phone>+49241803380092</phone>
    <email>vdeserno@ukaachen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Amrei Pelzer</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amrei Pelzer</last_name>
      <phone>00492418035768</phone>
      <email>apelzer@ukaachen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <lastchanged_date>February 16, 2016</lastchanged_date>
  <firstreceived_date>October 15, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute coronary syndrom</keyword>
  <keyword>Chronic obstructive pulmonary disease</keyword>
  <keyword>Myocardial infarction</keyword>
  <keyword>Blood based biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
